EXPERIENCE

Andy’s representative matters have included advising:

• EQT on a variety of transactions including:
  • its portfolio company BlueStep Bank on its acquisition of Bank2 ASA
  • its acquisition of leading enterprise software provider IFS AB alongside TA Associates
  • its and its portfolio company IVC Evidensia on the acquisition of VetStrategy, a leading Canadian veterinary care provider
  • its additional substantial investment and renewed long-term commitment in IVC Evidensia
  • its and its portfolio company Galderma on a $1 billion private placement
  • the sale of Anticimex, a global pest control specialist
  • the separation of software solutions provider WorkWave from IFS
  • its sale of leading medical device company HTL-Strefa to Investindustrial
  • its minority stake sale in Anticimex, a leading global specialist in preventive pest control
  • the combination of IVC and Evidensia
  • the disposal of Atos Medical, the global medical technology leader in laryngectomy care, to PAI
• Brighton Park Capital on its investment in PortSwigger, an application security software provider
• TenCate Grass Holding B.V. and Crestview Partners on the sale of a majority stake in TenCate to Leonard Green & Partners
• Triton on a variety of transactions including:
  • its €5 billion Triton IV Continuation Fund
  • its sale of Polygon to funds managed by AEA Investors
• Vitruvian Partners on the sale of a majority stake in Accountor Software, a leading provider of mission critical business software in Finland and Sweden, to KKR